FDA Approved: TORISEL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Torisel (temsirolimus) filed by Wyeth Pharmaceuticals (Pfizer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

SUPPL AP for TORISEL (TEMSIROLIMUS)